✦ LIBER ✦

The therapeutic efficacy of rosiglitazone is enhanced in sulphonylurea-treated patients with type 2 diabetes

✍ Scribed by H. Itakura; F. Abbasi; C. Lamendola; M. Basina; G. Reaven

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enhancement of insulin-stimulated myocar

✍ K. Hällsten; K. A. Virtanen; F. Lönnqvist; T. Janatuinen; M. Turiceanu; T. Rönne 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Effect of early addition of rosiglitazon

✍ J. Rosenstock; B. J. Goldstein; A. I. Vinik; M. Colleen O'Neill; L. E. Porter; M 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

Effect of ABCA1 variant on atherogenic d

✍ S. E. Park; E. S. Kang; D. H. Kim; S. K. Kim; J. H. Lee; C. W. Ahn; H. C. Lee; B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Hypoglycaemia in patients with type 2 di

✍ P. Vexiau; P. Mavros; G. Krishnarajah; R. Lyu; D. Yin 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

Metabolic effects of telmisartan and irb

✍ G. Derosa; E. Fogari; A. D'Angelo; A. F. G. Cicero; S. A. T. Salvadeo; P. D. Rag 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

A comparison of repaglinide and glibencl

✍ R. Landgraf; H. J. G. Bilo; P. G. Müller 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 103 KB